Alteration of interleukin 2 (IL-2) pharmacokinetics and function by IL-2 antibodies induced after treatment of colorectal carcinoma patients with a combination of monoclonal antibody 17-1A, granulocyte macrophage colony-stimulating factor, and IL-2 (Q73877518)
Jump to navigation
Jump to search
scientific article published on 01 May 2001
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Alteration of interleukin 2 (IL-2) pharmacokinetics and function by IL-2 antibodies induced after treatment of colorectal carcinoma patients with a combination of monoclonal antibody 17-1A, granulocyte macrophage colony-stimulating factor, and IL-2 |
scientific article published on 01 May 2001 |
Statements
Alteration of interleukin 2 (IL-2) pharmacokinetics and function by IL-2 antibodies induced after treatment of colorectal carcinoma patients with a combination of monoclonal antibody 17-1A, granulocyte macrophage colony-stimulating factor, and IL-2 (English)
Hjelm Skog AL
Wadhwa M
Gharizadeh B
Bird C
Ragnhammar P
Thorpe R